109 related articles for article (PubMed ID: 15373030)
1. [Combined treatment with fusion inhibitor. HIV-1 viruses under control longer].
MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373030
[No Abstract] [Full Text] [Related]
2. [Strategies for combating resistances in HIV therapy--an exemplifying case].
Stoehr A
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():70-1. PubMed ID: 15373056
[No Abstract] [Full Text] [Related]
3. Use of darunavir and enfuvirtide in a pregnant woman.
Sued O; Lattner J; Gun A; Patterson P; Abusamra L; Cesar C; Fink V; Krolewiecki A; Cahn P
Int J STD AIDS; 2008 Dec; 19(12):866-7. PubMed ID: 19050223
[TBL] [Abstract][Full Text] [Related]
4. [Fusion inhibitors. One year therapy with T-20--initial evaluation].
Goebel FD
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046
[No Abstract] [Full Text] [Related]
5. [HIV-1 fusion inhibitor improves treatment in HIV-1-resistant patients].
Blasko M
Dtsch Med Wochenschr; 2003 May; 128(19):1032. PubMed ID: 12774800
[No Abstract] [Full Text] [Related]
6. Analysis of a switch from enfuvirtide to raltegravir in patients with undetectable viral load: efficacy and quality of life at 24 weeks.
Sayana S; Prosser P; Ricaurte JC; Sanchez S; Hamwi G; Hershey-Weber J; Chien C; Easley A; Nguyen T; Wilson L; Khanlou H
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):85-6. PubMed ID: 19369697
[No Abstract] [Full Text] [Related]
7. European Commission approves Fuzeon following FDA approval--first HIV-fusion inhibitor in fight against HIV.
Infection; 2003 Aug; 31(4):7-8. PubMed ID: 14562955
[No Abstract] [Full Text] [Related]
8. A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.
Beatty G; Hunt P; Smith A; Hoh R; Huang W; Martin J; Deeks SG
Antivir Ther; 2006; 11(3):315-9. PubMed ID: 16759047
[TBL] [Abstract][Full Text] [Related]
9. Achieving rapid reduction of HIV-1 viral load in HIV-positive pregnant women close to term - an obstetric/medical emergency: a review of three cases.
Adeyemo A; Wood C; Govind A
Int J STD AIDS; 2013 Jul; 24(7):591-2. PubMed ID: 23970779
[TBL] [Abstract][Full Text] [Related]
10. Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.
Viard JP; Fagard C; Chaix ML; Rouzioux C; Bouteloup V; Bentata M; de Verdière NC; Pahlavan G; Weiss L; Lévy Y; Chêne G;
AIDS; 2009 Jul; 23(11):1383-8. PubMed ID: 19461505
[TBL] [Abstract][Full Text] [Related]
11. Enfuvirtide: a new class of antiretroviral therapy for HIV infection.
Leao JC; Frezzini C; Porter S
Oral Dis; 2004 Nov; 10(6):327-9. PubMed ID: 15533206
[TBL] [Abstract][Full Text] [Related]
12. Selective increase in serum IgE following enfuvirtide administration in HIV-1 infected multidrug resistant patients.
Hasson H; Biswas P; Galli L; Burastero SE; Danise A; Bigoloni A; Carini E; Locatelli M; Vecchi A; Lazzarin A; Castagna A
New Microbiol; 2006 Oct; 29(4):223-30. PubMed ID: 17201088
[TBL] [Abstract][Full Text] [Related]
13. Preventing viral entry. Fusion inhibitors.
Marks N
Posit Living; 1999 Mar; 8(2):13. PubMed ID: 12491997
[No Abstract] [Full Text] [Related]
14. Enfuvirtide doubles chances for suppression.
AIDS Patient Care STDS; 2004 Sep; 18(9):550. PubMed ID: 15630779
[No Abstract] [Full Text] [Related]
15. Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load.
Vaidya NK; Rong L; Marconi VC; Kuritzkes DR; Deeks SG; Perelson AS
PLoS Comput Biol; 2010 Nov; 6(11):e1001012. PubMed ID: 21124866
[TBL] [Abstract][Full Text] [Related]
16. [HIV infections: further options for combination therapy].
Hildegard K
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1523. PubMed ID: 12899165
[No Abstract] [Full Text] [Related]
17. Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients.
Wiznia A; Church J; Emmanuel P; Eppes S; Rowell L; Evans C; Bertasso A;
Pediatr Infect Dis J; 2007 Sep; 26(9):799-805. PubMed ID: 17721374
[TBL] [Abstract][Full Text] [Related]
18. Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patients.
Salzberger B; Däumer M; Gute P; Jaeger H; Knechten H; van Lunzen J; Mauss S; Mayr C; Moll A; Plettenberg A; Rockstroh J; Staszewski S; Stellbrink HJ; Stoll M; Sturmer M
Eur J Med Res; 2007 Mar; 12(3):93-102. PubMed ID: 17507306
[TBL] [Abstract][Full Text] [Related]
19. Virological fitness of HIV in patients with resistance to enfuvirtide.
Chibo D; Roth N; Roulet V; Skrabal K; Gooey M; Carolan L; Nicholls J; Papadakis A; Birch C
AIDS; 2007 Sep; 21(14):1974-7. PubMed ID: 17721108
[TBL] [Abstract][Full Text] [Related]
20. [Enfuvirtide].
Gerstoft J
Ugeskr Laeger; 2004 Nov; 166(48):4355-7. PubMed ID: 15587625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
